Topline Data from 52-week Phase 3 Study Expected in Late 2025 –CAMBRIDGE, Mass., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, ...

Thermo Fisher Scientific, which has a laboratory in Center Valley and an Allentown location, made special note of the new products it launched in the third quarter of 2024.

Genetic tests showed that certain patients were predisposed to brain injuries if they took the drugs. That information ...

Antibody-drug conjugates (ADCs) have emerged as a promising approach in cancer therapy, offering a 'magic bullet' strategy ...

Palleos Healthcare has a distinguished history of advancing medical innovations, leveraging its extensive experience and network to accelerate the development of new therapies. By integrating academic ...

The University of California, San Diego (UCSD) is actively seeking participants for five ongoing clinical trials focused on ...

Drug development in oncology is historically challenging, exhibiting a very high attrition rate, with low rates of approval for novel treatments when compared to other therapeutic areas. At present, ...

Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced Medidata Rave Lite, an extension of the company’s gold-standard ...

SAVANNAH, Georgia — There’s no medical treatment for Charcot-Marie-Tooth (CMT) disease, a debilitating neurologic disorder ...

University College Dublin (UCD) is leading MpoxVax AFRIVAC, a new €1.3 million international consortium that aims to rapidly deploy technology and develop new knowledge to end the current Mpox ...